LncRNA-CASC8 polymorphisms have been demonstrated to increase the risk of esophageal cancer and lung adenocarcinoma [32, 33], but the role in PAAD is first revealed in the present study. Here, CASC8 is linked to pancreatic adenocarcinoma.